Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
Clinical trial NCT03282240 · COMPLETED
Trial details
- NCT number
- NCT03282240
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2017-11-02
- Enrollment
- 2670
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.